Seton Hall Law is recognized as a leader in compliance education by multi-national
companies doing business globally.
[email protected] | 973-642-8382
We offer seven healthcare compliance programs annually in five different countries. These intensive, multi-day compliance education programs are designed to set a baseline for health care compliance knowledge and prepare professionals to better understand and respond to the myriad legal, regulatory, and ethical issues faced by life sciences manufacturers. Program participants leave with the knowledge, skills, and strategies they need to effectively manage their companies' compliance activities.
Program Postponed & New Dates To Be Announced Our Middle East Healthcare Compliance Certificate Program will cover emergent compliance issues in the life sciences industry.
March 3-6, 2025(in-person or hybrid)This intensive, multi-day educational health care compliance program addresses the myriad of legal, regulatory, and compliance issues encountered by pharmaceutical, biotech, and medical device manufacturers doing business in the Asia-Pacific region.
March 24-27, 2025(in-person or hybrid)The pharmaceutical, biotech, and medical device industries are increasingly facing a more challenging regulatory and enforcement landscape throughout Latin America (LATAM).
May 13-15, 2025 (virtual)Seton Hall Law's Advanced Healthcare Compliance Certificate Program (ADVANCED) is an intensive, three-day virtual workshop designed for experienced health care compliance and legal professionals who are looking for a deeper dive into key compliance risks, strategic decision making, and policy execution.
June 2-5, 2025 (in-person)October 6-9, 2025 (in-person or hybrid)This four-day healthcare compliance certificate program immerses attendees in the statutes, regulations, and other guidance that comprise the body of law known as “fraud and abuse law.”
June 6, 2025 (in-person)October 10, 2025 (in-person or hybrid)Join Seton Hall Law School faculty and respected industry leaders for an advanced supplement to the extraordinarily popular U.S. Healthcare Compliance Certificate Program, covering emergent issues in life sciences relating to prescription drugs and medical devices.
